Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypercytokinemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04351243
What this trial is testing

Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

Who this might be right for
COVID-19
Kinevant Sciences GmbH 227
Not applicableTemporarily pausedNCT04385771
What this trial is testing

Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation

Who this might be right for
Coronavirus InfectionCOVIDSARS-CoV 2+3 more
Dr. Alexander Supady 80
Large-scale testing (Phase 3)Study completedNCT04362813
What this trial is testing

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

Who this might be right for
Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia
Novartis Pharmaceuticals 454
Testing effectiveness (Phase 2)Ended earlyNCT04356690
What this trial is testing

Etoposide in Patients With COVID-19 Infection

Who this might be right for
COVID-19
Boston Medical Center 8
Testing effectiveness (Phase 2)UnknownNCT04869579
What this trial is testing

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.

Who this might be right for
Covid19
CHRISTUS Health 100
Early research (Phase 1)Study completedNCT02761915
What this trial is testing

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

Who this might be right for
Relapsed or Refractory Neuroblastoma
Cancer Research UK 17
Not applicableNot Yet RecruitingNCT07393087
What this trial is testing

Jafron Cytokine Adsorber During Pediatric Open-Heart Surgeries

Who this might be right for
Cardiac Surgery RecoveryInflammationComplex Cardiovascular Surgery With Cardiopulmonary Bypass+2 more
Centre Hospitalier Universitaire Vaudois 20
Not applicableUnknownNCT04413747
What this trial is testing

Yoga Pranayama Adjuvant to Treat Burden COVID-19

Who this might be right for
Coronavirus InfectionCytokine StormMental Disorder
Health Ricerca e Sviluppo S.R.L. 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04458298
What this trial is testing

Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients

Who this might be right for
COVID-19
Ashvattha Therapeutics, Inc. 28
Not applicableStudy completedNCT03974386
What this trial is testing

Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Severe Septic Shock

Who this might be right for
Sepsis, SevereSeptic Shock
National Taiwan University Hospital 12
Not applicableLooking for participantsNCT05146336
What this trial is testing

CytOSorb TreatMent Of Critically Ill PatientS Registry

Who this might be right for
Septic ShockAcute Respiratory Distress SyndromeTrauma+15 more
CytoSorbents, Inc 3,000
Testing effectiveness (Phase 2)WithdrawnNCT04378244
What this trial is testing

CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19

Who this might be right for
COVID-19Cytokine StormAcute Respiratory Distress Syndrome
Aveni Foundation
Not applicableUnknownNCT04388514
What this trial is testing

Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure

Who this might be right for
SARS-CoV-2 Respiratory Failure
Azienda Sanitaria-Universitaria Integrata di Udine 90
Testing effectiveness (Phase 2)UnknownNCT05013034
What this trial is testing

Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients

Who this might be right for
SARS-CoV-2 Acute Respiratory DiseaseSARS-CoV2 InfectionCytokine Storm
Fort Worth Clinical Sciences Working Group 300
Early research (Phase 1)Looking for participantsNCT07169487
What this trial is testing

Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study

Who this might be right for
Cytokine Release SyndromeICANS
Institute of Hematology & Blood Diseases Hospital, China 18
Testing effectiveness (Phase 2)Ended earlyNCT04365985
What this trial is testing

Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeSevere Acute Respiratory Syndrome (SARS)+1 more
Corewell Health East 70
Large-scale testing (Phase 3)Study completedNCT04643678
What this trial is testing

Anakinra in the Management of COVID-19 Infection

Who this might be right for
Covid19PneumoniaCytokine Release Syndrome+2 more
Hamad Medical Corporation 80
Testing effectiveness (Phase 2)UnknownNCT04781803
What this trial is testing

Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome

Who this might be right for
Stem Cell Transplant ComplicationsCytokine Release Syndrome
Hospital Universitario Dr. Jose E. Gonzalez 32
Early research (Phase 1)Study completedNCT04412785
What this trial is testing

Cyclosporine in Patients With Moderate COVID-19

Who this might be right for
COVID-19
University of Pennsylvania 11
Not applicableStudy completedNCT02020525
What this trial is testing

Blood Transfusions and Immune Response

Who this might be right for
Infection After TransfusionTransfusion-related Immunomodulation ReactionCytokine Storm+1 more
Aretaieion University Hospital 58
Next Page